Non-Invasive Detection of SARS-CoV-2 Antigen in Saliva versus Nasopharyngeal Swabs Using Nanobodies Conjugated Gold Nanoparticles

Bibliographic Information
Authors: Kamel M.; Maher S.; El-Baz H.; Salah F.; Sayyouh O.; Demerdash Z.
Journal: Tropical Medicine and Infectious Disease
Publisher: MDPI
Publication Date: 13 June 2022
Volume / Issue: Volume 7 / Issue 6
Article No.: 102
ISSN: 24146366
DOI: 10.3390/tropicalmed7060102
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Kamel M., Immunology Department, Theodor Bilharz Research Institute, Giza, 12411, Egypt; Maher S., Immunology Department, Theodor Bilharz Research Institute, Giza, 12411, Egypt; El-Baz H., Immunology Department, Theodor Bilharz Research Institute, Giza, 12411, Egypt; Salah F., Immunology Department, Theodor Bilharz Research Institute, Giza, 12411, Egypt; Sayyouh O., Infection Control Department, Theodor Bilharz Research Institute, Giza, 12411, Egypt; Demerdash Z., Immunology Department, Theodor Bilharz Research Institute, Giza, 12411, Egypt
Abstract
The development of sensitive, non-invasive tests for the detection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antigens is imperative, and it is still challenging to manage the extent of infection throughout the population. Here, we designed and optimized a sandwich enzyme-linked immunosorbent assay (ELISA) protocol for SARS-CoV-2 S1 antigen detection in saliva. Both saliva samples and nasopharyngeal swabs were collected from 220 real-time quantitative polymerase chain reaction (RT-qPCR)-confirmed positive and negative cases. S1 protein receptorbinding domain (RBD) nanobodies were efficiently conjugated with 40 nm gold nanoparticles (AuNPs) and employed as antigen detection probes in the developed system, while recombinant S1 monoclonal antibodies (S1mAbs) were employed as antigen capture probes. After checkerboard assays and system optimization, the clinical samples were tested. In saliva, the developed ELISA system showed the highest sensitivity (93.3) for samples with cycle threshold (Ct) values ≤ 30; interestingly, high sensitivity (87.5 and 86%) was also achieved for samples with Ct values ≤35 and ≤40, respectively, compared with 90, 80 and 88% sensitivity rates for nasopharyngeal swabs with the same categorized Ct values. However, the specificity was 100%, and no cross-reactions were detected with Middle East respiratory syndrome coronavirus (MERS-CoV) or SARS-CoV antigens. These results reveal that our protocol could be established as an efficient and sensitive, non-invasive diagnostic tool for the early detection of SARS-CoV-2 infection using easily collectable saliva samples. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Keywords
diagnosis; ELISA; nanobodies; saliva; SARS-CoV-2; coronavirus protein; gold nanoparticle; monoclonal antibody; rbd nanobody conjugated gold nanoparticle; S1 monoclonal antibody; S1 protein; unclassified drug; adult; aged; antigen detection; Article; controlled study; coronavirus disease 2019; cycle threshold value; diagnostic test accuracy study; female; human; intermethod comparison; male; Middle East respiratory syndrome coronavirus; nasopharyngeal swab; non invasive measurement; nonhuman; real time reverse transcription polymerase chain reaction; sandwich ELISA; sensitivity and specificity; Severe acute respiratory syndrome coronavirus 2
Citation Information
Scopus Citations: 11
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
